Others 8

Others 8

Others 8 related products

Structure Cat No. Product Name CAS No. Product Description
V3542 GSK3004774 2138814-32-9 GSK3004774 is a novel, potent, nonabsorbable agonist ofCaSR, with anpEC50of 7.3, 6.6 and 6.5 for human, mouse and rat CaSR, respectively.
V3593 GSK318689 1972617-87-0 GSK3186899 (also known as DDD-853651) is a novel and potent inhibitor of cdc-2-related kinase 12 (CRK12), with anEC50of 1.4 μM forL.
V3617 GSK3395879 2215852-91-6 GSK3395879 is a novel, potent, selective and orally bioavailable transient receptor potential vanilloid-4 (TRPV4) antagonist with anIC50of 1 nM for hTRPV4.
V3604 GSK376501A 1010412-80-2 GSK376501A is a novel,, potent and selective peroxisome proliferator-activated receptor gamma (PPARγ) modulator that has the potential for the treatment of type 2 diabetes mellitus.
V4394 INDACRINONE 57296-63-6 Indacrinone (MK196; Indacrynic acid; Indanone)is an investigational loop diuretic which can be used in patients of gout with hypertension as an antihypertensive because it decreases reabsorption of uric acid.
V4379 IPILIMUMAB 477202-00-9 Ipilimumab (trade name Yervoy; also known as MDX-010; BMS-734016) is a fully human monoclonal IgG1κ antibody against the cytotoxic T-lymphocyte antigen-4 (CTLA-4), which is an immune-inhibitory molecule expressed in activated T cells and in suppressor T regulatory cells.
V2120 JNJ-18038683 851373-91-6 JNJ-18038683 is a novel and potent antagonist of 5-Hydroxytryptamine Type 7 (5-HT7) receptor withpKisof 8.19, 8.20 for rat and human 5-HT7in HEK293 cells, respectively.
V2118 JNJ-47965567 1428327-31-4 JNJ-47965567 is a novel, potent,centrally permeable, high affinity and selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), which is a ligand-gated ion channel.
V3546 KD-3010 934760-90-4 KD-3010 is a potent, orally bioactive, and selective agonist of peroxisome proliferator-activated receptordelta(PPARδ)that can be potentially used for the treatment of diabetes and obesity.
V4099 KMUP-1 81996-46-5 KMUP-1, a xanthine derivative, has been demonstrated to modulate K+-channel activity in smooth muscles and is a stimulator of the NO/sGC/cGMP pathway.
V4100 KMUP-3 421556-16-3 KMUP-3, a xanthine derivative, has been demonstrated to modulate K+-channel activity in smooth muscles and is a stimulator of the NO/sGC/cGMP pathway.
V4102 KT5823 126643-37-6 KT5823 (KT-5823),a staurosporine-related analog,is a selective inhibitor of protein kinase G (PKG) with anticancer activity.
V2591 L755507 159182-43-1 L-755,507 isidentified as a potent and selective β3 adrenergic receptor partial agonist with EC50 of 0.43 nM, it displayed > 1000-fold selective over β1- and β2-adrenoceptors (EC50 values are 0.43, 580 and > 10000 nM for activation of cloned human β3-, β1- and β2-adrenoceptors respectively).
V2251 LBQ-657 sodium 149709-44-4 Sacubitril (Desethyl Sacubitril) is an active inhibitor of neprilysin (NEP).
V3139 LLY-284 2226515-75-7 LLY-284 (LLY284) is a negative control and tool compound forLLY-283.
V2137 LY-309887 127228-54-0 LY309887 is a novel and potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT) withKiof 6.5 nM, and has antitumor activity.
V2141 LY285434 159748-08-0 LY285434 is an angiotensin II receptor blocker (antagonist).
V3809 LY3104607 1795232-22-2 LY3104607 is a potent, selective and orally available G Protein-Coupled Receptor 40 (GPR40) agonist with potential antidiabetic application.
V3905 MACIMORELIN 381231-18-1 Macimorelin (formerly known as UMV-1843;EP-1572;AEZS-130; JMV1843; trade name:Macrilen) is a synthetic small molecule agonist of growth hormone secretagogue receptor that has been approved to diagnose growth hormone deficiency.
V3904 MACIMORELIN ACETATE 945212-59-9 Macimorelin acetate (formerly AEZS-130; EP-1572; JMV-1843; trade name:Macrilen), the acetate salt form of Macimorelin, is a novel and potent synthetic small molecule growth hormone secretagogue receptor agonist approved in 2018 for use in the diagnosis of adult growth hormone deficiency.
Contact Us Back to top